FOXO4-DRI
ResearchA senolytic peptide designed to selectively trigger apoptosis in senescent (zombie) cells. Researched as a potential anti-aging intervention.
LongevityAnti-AgingSenolytic
Half Life
Unknown
Time to Results
Weeks
Administration
SubQ injection
🐾 Griffin's Research Scorecard
Research Strength
Human Data
Animal Data
Long-Term Data
Beginner Friendly
Storage Difficulty
Injection FrequencyCycled (not daily)
Cost$$$
🐾 Griffin Says...
Senolytic research is one of the most exciting frontiers in aging science. Senescent cells (sometimes called zombie cells) accumulate as we age and contribute to tissue dysfunction. FOXO4-DRI was shown to clear them in mouse models with striking results. Very early human data only.
Benefits
- Senescent cell clearance
- Potential tissue rejuvenation
- Anti-aging research
- FOXO4-p53 pathway disruption
Best For
- Advanced longevity research
- Senolytic research
- Anti-aging
Body Systems
CellularImmune
Mechanisms of Action
- Disrupts FOXO4-p53 protein interaction in senescent cells
- Triggers apoptosis specifically in zombie cells
- Spares healthy cells
Side Effects
| Effect | Frequency | Severity |
|---|---|---|
| Unknown long-term profile | Unknown | Unknown |
| Potential inflammatory response as senescent cells clear | Theoretical | Mild-Moderate |
Contraindications
Extremely limited safety data, advanced research compound only
Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open Calculator